0001144204-14-022267.txt : 20140411
0001144204-14-022267.hdr.sgml : 20140411
20140411210138
ACCESSION NUMBER: 0001144204-14-022267
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140409
FILED AS OF DATE: 20140411
DATE AS OF CHANGE: 20140411
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: New York
STATE: NY
ZIP: 10011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TALLARIGO LORENZO
CENTRAL INDEX KEY: 0001276039
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 14761246
MAIL ADDRESS:
STREET 1: 18 DESBROSSES STREET
CITY: NEW YORK
STATE: NY
ZIP: 10013
4
1
v374633_4.xml
OWNERSHIP DOCUMENT
X0306
4
2014-04-09
0
0001270073
INTERCEPT PHARMACEUTICALS INC
ICPT
0001276039
TALLARIGO LORENZO
C/O INTERCEPT PHARMACEUTICALS, INC.
450 W. 15TH STREET, SUITE 505
NEW YORK
NY
10011
1
0
1
0
Common Stock
2014-04-09
4
S
0
318695
320.00
D
5620195
I
See Footnote
Common Stock
2014-04-10
4
X
0
865381
10.40
A
6485576
I
See Footnote
Common Stock
2014-04-10
4
S
0
30623
293.91
D
6454953
I
See Footnote
Common Stock
1640
D
Warrants to Purchase Common Stock
10.40
2014-04-10
4
X
0
865381
0
D
2015-01-20
Common Stock
865381
0
I
See Footnote
Held by Genextra S.p.A. Dr. Tallarigo is the chief executive officer of Genextra S.p.A. and, in such capacity, Dr. Tallarigo exercises voting control over the shares of common stock owned by Genextra S.p.A. and investment control over such shares as authorized by the board of directors of Genextra S.p.A. Dr. Tallarigo disclaims beneficial ownership with respect to any such shares, except to the extent of his pecuniary interest therein, if any.
Represents shares of common stock sold by Genextra S.p.A. in a public offering on April 9, 2014 pursuant to a registration statement on Form S-3 (File No. 333-194974).
Warrants to purchase an aggregate of 865,381 shares of common stock were exercised on a cashless basis by Genextra S.p.A. on April 10, 2014, resulting in the issuance by the Issuer of an aggregate of 834,758 shares of common stock based on a fair market value of $293.91 per share, as determined by the average of the high ($301.80) and low ($286.01) trading price on April 9, 2014, the trading day immediately preceding the date of exercise.
Warrants were fully exercisable as of the date of exercise.
/s/ Bryan Yoon, as attorney-in-fact
2014-04-11